Browse > Article
http://dx.doi.org/10.7231/JON.2011.22.3.101

Research Performance Evaluation Based on Quantitative Information Analysis in the Field of Herbal Medicine for Dementia Treatment  

Jeon, Won-Kyung (Creative Research Laboratory, Korea Institute of Oriental Medicine)
Han, Chang-Hyun (TKM Information Research Division, Korea Institute of Oriental Medicine)
Kang, Jong-Seok (Information Analysis Center, Korea Institute of S&T Information)
Heo, Eun-Jung (Creative Research Laboratory, Korea Institute of Oriental Medicine)
Han, Joong-Su (Dept. Biological Sciences, Kon-Kuk University)
Lee, Young-Joon (Dept. of Preventive Medicine, College of Oriental Medicine, Daegu Haany University)
Publication Information
Journal of Oriental Neuropsychiatry / v.22, no.3, 2011 , pp. 101-113 More about this Journal
Abstract
Objectives : Trend of R&D of herbal medicine for dementia treatment was examined based on the quantitative information analysis for establishing the national strategy of research on dementia treatment with oriental medicine. Methods : Definition was made to clarify the technology for development of herbal medicine for dementia treatment. Based on the initial keyword provided by experts in the field, queries were compounded to conduct search in the search engines of WoS and DWPI. The raw data (papers or patents) extracted from the initial search were examined by expert-review before objects of analysis were determined. Then, the accumulated data was analyzed in terms of year, country and organization, which led to examination of the trend of R&D. And the research performance evaluation for dementia treatment technologies was also made in terms of country, organization and researcher based on the forward citation analysis. The international cooperation intensity was examined on the basis of analysis of network by researcher before analysis results were put together to select lead researchers. Results : According to the quantitative information analysis of 1,330 articles that were selected as analysis objects, the number of papers on natural products research for dementia treatment has increased by around 4.6 times in recent five years. This indicates that the intensive studies have been underway recently. It was found to be the US that had the highest level in research filed of herbal medicine for dementia treatment and the highest capacity of international cooperation for that purpose. On the contrary, Korea had the share of papers at 5.1%, the number of countries in cooperation research at 8, and the article quality index at 0.40, showing that the qualitative level was insufficient, compared to the quantitative outcome. In particular, Korea was found to have no intensity of international cooperation among researchers. In case of patent, the results of information analysis of 305 patents selected as analysis objects demonstrated that China had the highest share while Korea had the very low frequency of patent application quantitatively. Conclusions : In this study, the research to develop herbal medicine for dementia treatment has recently drawn much attention that has spread around the globe. Therefore, these results suggest establishing the strategy to develop technology for dementia treatment with oriental medicine in the future based on quantitative information analysis.
Keywords
Herbal medicine; Dementia; Quantitative information analysis; Paper; Patent;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Jesky R, Hailong C. Are herbal compounds the next frontier for alleviating learning and memory impairments? An integrative look at memory, dementia and the promising therapeutics of traditional chinese medicines. Phytother Res. 2011;25(8):1105-18.   DOI   ScienceOn
2 Adams M, Gmunder F, Hamburger M. Plants traditional used in age related brain disorders-A survey of ethnobotanical literature. Journal of Ethnopharmacology. 2007;113:363-81.   DOI   ScienceOn
3 Kang JS, Lee HJ, Moon YH. Systemnatic approch for monitoring competitor's technologycal challenges based upon patent analysis. Information 13. 2010;339-52.
4 이우형. 과학기술정보분석을 통한 신기술 도출방법론 및 지표개발. 서울:과학기술정책연구원. 2005:1-88.
5 오세량. 식물추출물을 이용한 천연물의약의 현황. Bioin 스페셜Zine. 2011;20:1-10.
6 대한신경정신의학회 편. 신경정신의학 2판. 서울:중앙문화사. 2011:498.
7 김재승, 오승준, 문대혁. 퇴행성 뇌질환에서의 분자영상. J Korean Med Assoc 2009;52(2):151-67.   DOI   ScienceOn
8 대한신경과학회 교과서편찬위원회. 신경학. 서울:군자출판사. 2007:171.
9 한원주, 김상태, 이충식, 박보라, 정은영, 김대현, 윤종현, 김진우, 강형원, 류영수, 김태헌. 장원환가감방 전탕액이 APP로 유도된 형질전환 초파리에서의 항치매 효과. 동의생리병리학회지. 2008;22(5):1215-22.
10 오병훈. 치매의 행동․정신 증상 진단 및 관리. J Korean Med assoc. 2009;52(11):1048.   DOI
11 전국한의과대학 신경정신과 교과서편찬위원회 편. 한의신경정신과학. 서울:집문당. 2007:327-8.
12 진귀연, 장사수. 실용중서의종합진단치료학. 북경:중국의약과기술출판사. 1990:824-6.
13 Hogogan DB. Progress update: Pharmacological treatment of Alzheimer's disease. Neuropsychiatric Disease and Treatment. 2007;3(5):569-78.
14 Chittaranjan Andrade, Rajiv Radhakrishnan. The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments. Indian J Psychiatry. 2009;51:12-25.   DOI   ScienceOn
15 Morphy, R, Rankovic, Z. Designing multiple legands-medicinal chemistry strategies and challenges. Current Pharmaceutical Design. 2009;15:587-600.   DOI   ScienceOn
16 국민건강보험공단 건강보험정책연구원. 2010 건강보험주요통계. 서울:국민건강보험공단. 2010:1-92.
17 Yan YX, Liang LZ, Zhou ZL. Clinical study of combined treatment with compound Reinhartdt and Sea Cumber Capsule and donopezil for vascular dementia. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27(10):887-90.
18 Seo JS, Yun JH, Baek IS, Leem YH, Kang HW, Cho HK, Lyu YS, Son HJ, Han PL. Oriental medicine Jangwonhwan reduces Abeta(1-42) level and beta-amyloid deposition in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease. J Ethnopharmacol. 2010;128(1):206-12.   DOI   ScienceOn
19 Yun YJ, Lee B, Hahm DH, Kang SK, Han SM, Lee HJ, Pyun KH, Shim I. Neuroprotective effect of palmul-chongmyeong-tang on ischemia-induced learning and memory deficits in the rat. Biol Pharm Bull. 2007;30(2):337-42.   DOI   ScienceOn
20 구진숙, 서부일, 박지하, 노성수 치매치료한 약 (처방 및 한약재) 연구 논문 동향 분석. 대한본초학회지. 2010;25(3):131-7.
21 Zimmermann G. R., Lehar J. Keith, C.T. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discovery Today. 2007;12:34-42.   DOI   ScienceOn
22 Frantz, S. Playing dirty. Nature. 2005;437:942-3.   DOI   ScienceOn
23 Nogami A, Sakata Y, Uchida N, Yamaguchi K, Kawasaki C, Shindo T, Kubota K, Katsurabayashi S, Takasaki K, Mishima K, Nishimura R, Fujiwara M, Iwasaki K. Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia. J Nat Med. 2011;65(2):275-81.   DOI   ScienceOn
24 De Caires S, Steenkamp V. Use of Yokukansan (TJ-54) in the treatment of neurological disorders: a review. Phytother Res. 2010;24(9):1265-70.   DOI   ScienceOn
25 Murakami Y, Zhao Q, Harada K, Tohda M, Watanabe H, Matsumoto K. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. Pharmacol Biochem Behav. 2005;81(3):616-25.   DOI   ScienceOn
26 Monji A, Takita M, Samejima T, Takaishi T, Hashimoto K, Matsunaga H, Oda M, Sumida Y, Mizoguchi Y, Kato T, Horikawa H, Kanba S. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):308-11.   DOI   ScienceOn
27 Tabira T. Development of new drugs for Alzheimer's disease. Brain Nerve. 2010;62(7):787-96.
28 Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(3):532-6.   DOI   ScienceOn